[Rapid desensitisation to tocilizumab in systemic idiopathic juvenile arthritis]

An Pediatr (Engl Ed). 2021 Mar;94(3):180-181. doi: 10.1016/j.anpedi.2020.06.007. Epub 2020 Oct 12.

[Article in Spanish]

Authors

Rosalaura Villarreal González¹, Sandra González Díaz², Cindy de Lira Quezada², Alejandra Macías Weinmann², Natalhie Acuña Ortega²

Affiliations

¹ Centro Regional de Alergia e Inmunología Clínica, Hospital Universitario «Dr. José Eleuterio González», Universidad Autónoma de Nuevo León, Monterrey, México. Electronic address: rosalauravillarrealg@gmail.com.
² Centro Regional de Alergia e Inmunología Clínica, Hospital Universitario «Dr. José Eleuterio González», Universidad Autónoma de Nuevo León, Monterrey, México.

PMID: 33060060
DOI: 10.1016/j.anpedi.2020.06.007

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal, Humanized*
Antirheumatic Agents*
Arthritis, Juvenile* / drug therapy
Child, Preschool
Drug Tolerance*
Female
Humans

Substances

Antibodies, Monoclonal, Humanized
Antirheumatic Agents
tocilizumab